Clinical application value of ultrasound-guided muscle plane block in patients with mediastinal tumor surgery

Clinical application value of ultrasound-guided parasternal block in patients undergoing substernotomy mediastinal tumor surgery

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200055315

Enrollment

Unknown

Registered

2022-01-06

Start date

2022-01-03

Completion date

Unknown

Last updated

2023-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mediastinal mass

Interventions

Group P:ultrasound guided parasternal block

Group S:serratus anterior plane block

Group C:placebo

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients aged over 18 years, ASA I-III, elective mediastinal mass resection, no gender limit.

Exclusion criteria

Exclusion criteria: 1. History of thoracic surgery; 2. History of mental or neurological disease; 3. Perioperative drug allergy; 4. Abnormal coagulation function; 5. Injection site infection or eczema; 6. Myasthenia gravis; 7. Those who meet the contraindications of ropivacaine.

Design outcomes

Primary

Measure	Time frame
postoperative quality of recovery;	—

Secondary

Measure	Time frame
pain rating scale score;IL-6;IL-18;ß endorphins;C-reactive protein;	—

Countries

China

Contacts

Public ContactFu Yu

Shanghai Pulmonary Hospital Affiliated to Tongji University

15755359070@163.com+86 15755359070

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026